Midterm Outcome of Branch Vessel Stenting for Superior Mesenteric Artery Malperfusion Complicating with Acute Aortic Dissection

Kensuke Uotani,Masato Yamaguchi,Takuya Okada,Tomoyuki Gentsu,Noriaki Sakamoto,Ryota Kawasaki,Takanori Taniguchi,Hirotaka Tomimatsu,Koji Sugimoto,Takamichi Murakami
DOI: https://doi.org/10.22575/interventionalradiology.2022-0045
2024-05-14
Abstract:Purpose: To investigate the midterm stent patency and patient prognosis after stenting for superior mesenteric artery malperfusion complicating with acute aortic dissection. Material and methods: Thirteen patients who underwent branch vessel stenting for superior mesenteric artery malperfusion between 2011 and 2021 in six institutions were retrospectively reviewed. By comparing pre- and postoperative computed tomography scans in the same plane, the length of the stent implanted in the superior mesenteric artery and the stent-to-vessel diameter ratio were measured. The technical and clinical success of stenting, midterm patient prognosis, and stent patency were evaluated. Results: Superior mesenteric artery stenting was technically successful in 12 patients (92.3%). The mean length of the stents implanted in the superior mesenteric artery was 61.3 ± 39.4 mm (range, 14-127 mm). The mean proximal and distal stent-to-vessel diameter ratios were 1.02 ± 0.16 and 1.30 ± 0.42, respectively. A weak correlation was found between the length of the stents implanted in the superior mesenteric artery and the distal stent-to-vessel diameter ratio (R2 = 0.34). Two major complications occurred, one of which resulted in death within 30 days, and 12 (92.3%) were clinically successful. Of these 12 patients, no recurrent intestinal ischemia occurred during the follow-up duration (mean, 45.2 months). Partial occlusion of the stent distal edge without intestinal ischemia was observed in one patient (distal stent-to-vessel diameter ratio = 2.33) 42 months after stenting. The overall survival rate and primary stent patency rate were 84.6% and 91.7%, respectively. Conclusions: Midterm stent patency and survival after superior mesenteric artery stenting for malperfusion were acceptable.
What problem does this paper attempt to address?